HERAN Partners
All figures cover the European funds tracked here since 1 January 2025, whether closed or still raising, and are compiled from public sources.
- Tracked funds
- 1
- Reported volume
- €90m
- Latest public closing
- 12 Feb 2026
Reported volume sums the public fund amounts tracked here, not the manager's firm-wide assets under management, so it may differ from totals on the manager's website.
Antwerp-based venture and growth capital firm investing in European HealthTech and MedTech.
Focus: European life sciences and healthcare, especially HealthTech and MedTech enabling technologies, with venture and growth capital for startups and scale-ups
12 February 2026: HERAN announced that HERAN HealthTech Fund II had reached €90m, moving towards a €120m target (company LinkedIn announcement).
Tracked funds
Seed and Series A in medtech, digital health and healthcare-enabling technologies.
- Health & Bio
- Europe
- Fund 2
- 12 Feb 2026
- HERAN Partners